Grifols, S.A Gross Profit 2012-2025 | GRFS

Grifols, S.A annual/quarterly gross profit history and growth rate from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.

Grifols, S.A gross profit for the quarter ending September 30, 2025 was $0.858B, a 18.78% increase year-over-year.
Grifols, S.A gross profit for the twelve months ending September 30, 2025 was $3.233B, a 24.03% increase year-over-year.
Grifols, S.A annual gross profit for 2024 was $3.024B, a 12% increase from 2023.
Grifols, S.A annual gross profit for 2023 was $2.7B, a 14.83% increase from 2022.
Grifols, S.A annual gross profit for 2022 was $2.351B, a 1.26% increase from 2021.

Grifols, S.A Annual Gross Profit (Millions of US $)
2024	$3,024
2023	$2,700
2022	$2,351
2021	$2,322
2020	$2,576
2019	$2,622
2018	$2,421
2017	$2,432
2016	$2,116
2015	$2,144
2014	$2,259
2013	$1,883
2012	$1,710
2011	$1,900

Grifols, S.A Quarterly Gross Profit (Millions of US $)
2025-09-30	$858
2025-06-30	$844
2025-03-31	$732
2024-09-30	$799
2024-06-30	$722
2023-06-30	$674
2023-03-31	$595
2022-06-30	$615
2021-06-30	$700
2019-06-30	$672
2018-06-30	$617
2017-06-30	$617
2017-03-31	$578
2016-12-31	$543
2016-09-30	$522
2016-06-30	$528
2016-03-31	$523
2015-12-31	$572
2015-09-30	$537
2015-06-30	$526
2015-03-31	$506
2014-12-31	$442
2014-09-30	$567
2014-06-30	$532
2014-03-31	$594
2013-12-31	$456
2013-09-30	$471
2013-06-30	$485
2013-03-31	$462
2012-12-31	$421
2012-09-30	$418
2012-06-30	$430
2012-03-31	$423
2011-12-31	$796
2011-09-30	$807

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$6.284B	$7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.450B	33.97
Zoetis (ZTS)	United States	$52.293B	18.72
Takeda Pharmaceutical (TAK)	Japan	$45.598B	9.31
Daiichi Sankyo, - (DSNKY)	Japan	$40.539B	20.19
BeOne Medicines - (ONC)	Switzerland	$37.820B	185.50
Sandoz Group AG (SDZNY)	Switzerland	$31.838B	0.00
United Therapeutics (UTHR)	United States	$21.270B	18.72
Merck (MKKGY)	Germany	$17.881B	11.02
Neurocrine Biosciences (NBIX)	United States	$15.235B	36.56
Shionogi (SGIOY)	Japan	$14.445B	13.27
Summit Therapeutics (SMMT)	United States	$13.549B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.091B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$12.978B	0.00
IPSEN (IPSEY)	France	$11.918B	0.00
Orion OYJ (ORINY)	Finland	$9.738B	27.82
Corcept Therapeutics (CORT)	United States	$9.256B	99.99
Eisai (ESAIY)		$8.400B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.305B	35.29
Ono Pharmaceutical (OPHLF)	Japan	$6.238B	18.97
Crinetics Pharmaceuticals (CRNX)	United States	$4.791B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.544B	0.00
NewAmsterdam Pharma (NAMS)	Netherlands	$4.224B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.838B	18.22
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.564B	0.00
Ocular Therapeutix (OCUL)	United States	$3.102B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.903B	9.26
Soleno Therapeutics (SLNO)	United States	$2.793B	0.00
Dyne Therapeutics (DYN)	United States	$2.752B	0.00
Hypermarcas (HYPMY)	Brazil	$2.737B	18.79
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.090B	24.77
Avadel Pharmaceuticals (AVDL)	Ireland	$2.086B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.911B	36.81
Harrow (HROW)	United States	$1.743B	106.96
BioCryst Pharmaceuticals (BCRX)	United States	$1.594B	94.62
Collegium Pharmaceutical (COLL)	United States	$1.537B	7.61
Ardelyx (ARDX)	United States	$1.509B	0.00
Oruka Therapeutics (ORKA)	United States	$1.461B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.439B	0.00
Savara (SVRA)	United States	$1.408B	0.00
Relay Therapeutics (RLAY)	United States	$1.392B	0.00
Cronos Group (CRON)	Canada	$1.250B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.190B	0.00
Xencor (XNCR)	United States	$1.180B	0.00
Nektar Therapeutics (NKTR)	United States	$1.113B	0.00
Evotec AG (EVO)	Germany	$1.069B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.012B	0.00
Enliven Therapeutics (ELVN)	United States	$1.001B	0.00
Theravance Biopharma (TBPH)	United States	$0.921B	38.66
Esperion Therapeutics (ESPR)	United States	$0.920B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.855B	0.00
Aquestive Therapeutics (AQST)	United States	$0.758B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.740B	6.61
Lyell Immunopharma (LYEL)	United States	$0.732B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.713B	0.00
ProKidney (PROK)	United States	$0.665B	0.00
Bioventus (BVS)	United States	$0.625B	12.80
4D Molecular Therapeutics (FDMT)	United States	$0.619B	0.00
Organogenesis (ORGO)	United States	$0.612B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.582B	13.77
Altimmune (ALT)	United States	$0.550B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.537B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.469B	0.00
Siga Technologies (SIGA)	United States	$0.463B	6.33
Akebia Therapeutics (AKBA)	United States	$0.441B	0.00
Galectin Therapeutics (GALT)	United States	$0.403B	0.00
Nature's Sunshine Products (NATR)	United States	$0.398B	23.69
USANA Health Sciences (USNA)	United States	$0.373B	10.42
Aclaris Therapeutics (ACRS)	United States	$0.352B	0.00
Avalo Therapeutics (AVTX)	United States	$0.337B	0.00
Larimar Therapeutics (LRMR)	United States	$0.335B	0.00
OmniAb (OABI)	United States	$0.310B	0.00
Fractyl Health (GUTS)	United States	$0.307B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.299B	0.00
Relmada Therapeutics (RLMD)	United States	$0.298B	0.00
Protara Therapeutics (TARA)	United States	$0.294B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.273B	0.00
Pyxis Oncology (PYXS)	United States	$0.268B	0.00
Heron Therapeutics (HRTX)	United States	$0.251B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.247B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.227B	0.00
Profound Medical (PROF)	Canada	$0.221B	0.00
MediWound (MDWD)	Israel	$0.211B	0.00
Surrozen (SRZN)	United States	$0.211B	0.00
Journey Medical (DERM)	United States	$0.208B	0.00
AleAnna (ANNA)	United States	$0.196B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.170B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.164B	0.00
Innate Pharma SA (IPHYF)	France	$0.160B	0.00
Gain Therapeutics (GANX)	United States	$0.159B	0.00
Incannex Healthcare (IXHL)	Australia	$0.146B	0.00
Cassava Sciences (SAVA)	United States	$0.142B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.134B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.119B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.116B	0.00
Prelude Therapeutics (PRLD)	United States	$0.108B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.107B	0.00
Avita Medical (RCEL)	United States	$0.106B	0.00
Vivani Medical (VANI)	United States	$0.098B	0.00
Context Therapeutics (CNTX)	United States	$0.096B	0.00
Plus Therapeutics (PSTV)	United States	$0.094B	0.00
Champions Oncology (CSBR)	United States	$0.093B	33.60
VAXART, INC (VXRT)	United States	$0.089B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.080B	0.00
Korro Bio (KRRO)	United States	$0.078B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.077B	0.00
Rafael Holdings (RFL)	United States	$0.076B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.075B	0.00
Assertio Holdings (ASRT)	United States	$0.073B	0.00
Dominari Holdings (DOMH)	United States	$0.071B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.065B	0.00
Lite Strategy (LITS)	United States	$0.063B	0.00
PolyPid (PYPD)	Israel	$0.062B	0.00
Nutriband (NTRB)	United States	$0.062B	0.00
Metagenomi (MGX)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.061B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.058B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Talphera (TLPH)	United States	$0.055B	0.00
Wellgistics Health (WGRX)	United States	$0.051B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.050B	0.00
Century Therapeutics (IPSC)	United States	$0.049B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.039B	0.00
ElectroCore (ECOR)	United States	$0.038B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.038B	31.62
Mural Oncology (MURA)	Ireland	$0.035B	0.00
FibroGen (FGEN)	United States	$0.034B	0.00
Klotho Neurosciences (KLTO)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
Inotiv (NOTV)	United States	$0.026B	0.00
Vyome Holdings (HIND)	United States	$0.026B	0.00
Scienture Holdings (SCNX)	United States	$0.025B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.025B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.023B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.023B	0.00
TherapeuticsMD (TXMD)	United States	$0.020B	0.00
Natural Alternatives (NAII)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Lipocine (LPCN)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.016B	0.00
Mangoceuticals (MGRX)	United States	$0.016B	0.00
Cosmos Health (COSM)	United States	$0.015B	0.00
Tempest Therapeutics (TPST)	United States	$0.015B	0.00
Heatwurx (PCSA)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.014B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
VYNE Therapeutics (VYNE)	United States	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Ainos (AIMD)	United States	$0.011B	0.00
BioVie (BIVI)	United States	$0.011B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.011B	0.00
CASI Pharmaceuticals (CASI)	China	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.010B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Aptorum Group (APM)	United Kingdom	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Lyra Therapeutics (LYRA)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
ProPhase Labs (PRPH)	United States	$0.005B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
CDT Equity (CDT)	United States	$0.003B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.002B	0.00
Aditxt (ADTX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Indivior (INDV)	United States	$0.000B	18.14
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Minerva Neurosciences (NERV)	United States	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00